Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125229462 | 12522946 | 2 | F | 201510 | 20160711 | 20160701 | 20160715 | EXP | US-ABBVIE-16P-163-1662781-00 | ABBVIE | 53.68 | YR | F | Y | 54.03000 | KG | 20160715 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125229462 | 12522946 | 1 | PS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 1048419 | 21402 | 137 | UG | QD | |||||||
125229462 | 12522946 | 2 | SS | ACETAMINOPHENHYDROCODONE BITARTRATE | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | 7.5/325 AT NIGHT | 88058 | BID | |||||||||
125229462 | 12522946 | 3 | SS | LYRICA | PREGABALIN | 1 | Unknown | M49795 | 0 | 50 | MG | CAPSULE | TID | ||||||
125229462 | 12522946 | 4 | SS | LYRICA | PREGABALIN | 1 | M49795 | 0 | |||||||||||
125229462 | 12522946 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | DOSE DECREASED IN RESPONSE TO AE | N | UNKNOWN | 0 | ||||||||
125229462 | 12522946 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | DOSE DECREASED | N | UNKNOWN | 0 | ||||||||
125229462 | 12522946 | 7 | SS | BONIVA | IBANDRONATE SODIUM | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
125229462 | 12522946 | 8 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | Nasal | SPRAY; ONLY TAKEN WHEN FEELS LIKE GOING TO LOSE VISION | 0 | ||||||||||
125229462 | 12522946 | 9 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | Nasal | SPRAY; ONLY TAKEN WHEN FEELS LIKE GOING TO LOSE VISION | 0 | ||||||||||
125229462 | 12522946 | 10 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 0 | 50000 | DF | TIW | ||||||||
125229462 | 12522946 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 0 | 50000 | DF | TIW | ||||||||
125229462 | 12522946 | 12 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Unknown | AT NIGHT | 0 | 2 | DF | TABLET | QD | ||||||
125229462 | 12522946 | 13 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Unknown | AT NIGHT | 0 | 2 | DF | TABLET | QD | ||||||
125229462 | 12522946 | 14 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Unknown | 0 | 40 | MG | QD | ||||||||
125229462 | 12522946 | 15 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Unknown | 0 | 40 | MG | QD | ||||||||
125229462 | 12522946 | 16 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 60 MG IN MORNING 30 MG AT NIGHT | 0 | BID | |||||||||
125229462 | 12522946 | 17 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 60 MG IN MORNING 30 MG AT NIGHT (TAKING 7-8 YEARS) | 0 | BID | |||||||||
125229462 | 12522946 | 18 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | AT NIGHT | 0 | 1 | MG | QD | |||||||
125229462 | 12522946 | 19 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | AT NIGHT | 0 | 1 | MG | QD | |||||||
125229462 | 12522946 | 20 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | 0 | 100 | MG | QD | ||||||||
125229462 | 12522946 | 21 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | ||||||||||||
125229462 | 12522946 | 22 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | ||||||||||||
125229462 | 12522946 | 23 | C | BACLOFEN. | BACLOFEN | 1 | Unknown | 0 | 20 | MG | |||||||||
125229462 | 12522946 | 24 | C | PROLIA | DENOSUMAB | 1 | Other | 0 | 1 | DF | |||||||||
125229462 | 12522946 | 25 | C | TOPAMAX | TOPIRAMATE | 1 | 0 | 200 | MG | BID | |||||||||
125229462 | 12522946 | 26 | C | TOPAMAX | TOPIRAMATE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125229462 | 12522946 | 1 | Hypothyroidism |
125229462 | 12522946 | 2 | Pain |
125229462 | 12522946 | 3 | Fibromyalgia |
125229462 | 12522946 | 4 | Nervous system disorder |
125229462 | 12522946 | 5 | Product used for unknown indication |
125229462 | 12522946 | 7 | Product used for unknown indication |
125229462 | 12522946 | 8 | Visual impairment |
125229462 | 12522946 | 10 | Product used for unknown indication |
125229462 | 12522946 | 12 | Restless legs syndrome |
125229462 | 12522946 | 14 | Blood pressure measurement |
125229462 | 12522946 | 15 | Headache |
125229462 | 12522946 | 16 | Muscle spasms |
125229462 | 12522946 | 17 | Depression |
125229462 | 12522946 | 18 | Insomnia |
125229462 | 12522946 | 19 | Dyskinesia |
125229462 | 12522946 | 20 | Anxiety |
125229462 | 12522946 | 21 | Depression |
125229462 | 12522946 | 22 | Insomnia |
125229462 | 12522946 | 23 | Muscle relaxant therapy |
125229462 | 12522946 | 24 | Product used for unknown indication |
125229462 | 12522946 | 25 | Migraine |
125229462 | 12522946 | 26 | Visual impairment |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125229462 | 12522946 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125229462 | 12522946 | Arthropathy | |
125229462 | 12522946 | Body height decreased | |
125229462 | 12522946 | Bone disorder | |
125229462 | 12522946 | Central pain syndrome | |
125229462 | 12522946 | Drug ineffective | |
125229462 | 12522946 | Fall | |
125229462 | 12522946 | Foot fracture | |
125229462 | 12522946 | Fracture | |
125229462 | 12522946 | Impaired driving ability | |
125229462 | 12522946 | Impaired work ability | |
125229462 | 12522946 | Muscle spasms | |
125229462 | 12522946 | Muscular weakness | |
125229462 | 12522946 | Osteitis | |
125229462 | 12522946 | Osteopenia | |
125229462 | 12522946 | Pain | |
125229462 | 12522946 | Upper limb fracture | |
125229462 | 12522946 | Vasodilatation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |